drugset / Trial / NCT00095368

APC-111 Once a Day (QD) for 7 Days vs. Penicillin Taken Four Times a Day (QID) for 10 Days in Patients With Strep Throat

NCT00095368

Phase 3 Completed 500 enrolled Advancis Pharmaceutical Corporation
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of the this study is to evaluate the safety of efficacy of APC-111 775 mg MP tablet once daily dosing for 7 days for treating patients with strep throat. The evaluation will look to confirm if APC-111 eliminates the bacterial infection (Streptococcus pyogenes).

Timeline

Start
2004-10
Primary completion
Completion
2005-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Amoxicillin Other / unclassified 775 mg

Indications